The aetiology of neurological complications of organic acidaemias—A role for the blood–brain barrier

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2006-10-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10545-006-0415-8PMID 17041745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural History, Outcome, and Treatment Efficacy in Children and Adults with Glutaryl-CoA Dehydrogenase Deficiency

  2006cited by this paper
• Intracerebral accumulation of glutaric and 3‐hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl‐CoA dehydrogenase deficiency

  2006cited by this paper
• Endothelial Effects of 3-Hydroxyglutaric Acid: Implications for Glutaric Aciduria Type I

  2006cited by this paper
• Functional and molecular identification of sodium‐coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons

  2006cited by this paper
• A diet-induced mouse model for glutaric aciduria type I.

  2006cited by this paper
• Neurological manifestations of organic acid disorders

  2005cited by this paper
• Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency

  2005cited by this paper
• Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort.

  2005cited by this paper
• Bioenergetics in Glutaryl-Coenzyme A Dehydrogenase Deficiency

  2005cited by this paper
• Pathomechanisms of neurodegeneration in glutaryl‐CoA dehydrogenase deficiency

  2004cited by this paper
• Glutaric aciduria type I and kynurenine pathway metabolites: A modified hypothesis

  2004cited by this paper
• Type I glutaric aciduria, part 1: Natural history of 77 patients

  2003cited by this paper
• NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d‐2‐hydroxyglutaric aciduria

  2002cited by this paper
• Cerebral dicarboxylate transport and metabolism studied with isotopically labelled fumarate, malate and malonate

  2002cited by this paper
• Urea cycle enzymes

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cited by this paper
• Transporter-mediated permeation of drugs across the blood-brain barrier.

  2000cited by this paper
• Glutaryl-CoA Dehydrogenase Deficiency in Spain: Evidence of Two Groups of Patients, Genetically, and Biochemically Distinct

  2000cited by this paper
• Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I

  1999cited by this paper
• Liver transplantation in urea cycle disorders

  1999cited by this paper
• Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.

  1999influential reference
• Methylmalonate toxicity in primary neuronal cultures.

  1998cited by this paper
• Neurological outcome of methylmalonic acidaemia

  1998cited by this paper
• Stroke-like encephalopathy in an infant with 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency

  1998cited by this paper
• Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.

  1996cited by this paper
• Argininosuccinic Aciduria: Clinical and Biochemical Findings in Three Children with the Late Onset Form, with Special Emphasis on Cerebrospinal Fluid Findings of Amino Acids and Pyrimidines

  1993cited by this paper
• Physiology and pathophysiology of organic acids in cerebrospinal fluid

  1993cited by this paper
• L‐2‐hydroxyglutaric acidemia: A novel inherited neurometabolic disease

  1992cited by this paper
• Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS.

  1981cited by this paper
• Glutaric aciduria: biochemical and morphologic considerations.

  1977cited by this paper

• Recent research advances in the biological function and molecular mechanism of methylmalonic acid

  2025cites this paper
• Therapeutic AASS inhibition by AAV-miRNA rescues glutaric aciduria type I severe phenotype in mice

  2025cites this paper
• Positive Clinical, Neuropsychological, and Metabolic Impact of Liver Transplantation in Patients With Argininosuccinate Lyase Deficiency

  2025cites this paper
• Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study

  2023cites this paper
• Euglycemic Diabetic Ketoacidosis Related to SGLT2 Inhibitor Use in a Patient With Cobalamin C Deficiency and Diabetes

  2023cites this paper
• Methylmalonic acid induces inflammatory response and redox homeostasis disruption in C6 astroglial cells: potential glioprotective roles of melatonin and resveratrol

  2022cites this paper
• Renal outcome and plasma methylmalonic acid levels after isolated or combined liver or kidney transplantation in patients with methylmalonic acidemia: A multicenter analysis.

  2022cites this paper
• Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology.

  2022cites this paper
• Impact of Propionic Acidemia on Brain Astrocytes

  2021cites this paper
• Methylmalonic Acid Impairs Cell Respiration and Glutamate Uptake in C6 Rat Glioma Cells: Implications for Methylmalonic Acidemia

  2021influential citation
• Methylmalonic Acid Compromises Respiration and Reduces the Expression of Differentiation Markers of SH-SY5Y Human Neuroblastoma Cells.

  2021cites this paper
• Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia

  2021cites this paper
• The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery.

  2021cites this paper
• Orthopaedic manifestations of glutaric acidemia Type 1

  2020cites this paper
• Audiological and otologic manifestations of glutaric aciduria type I

  2020cites this paper
• Methylmalonic acid compromises mitochondrial respiration and reduces the expression of markers of differentiation in SH-SY5Y human neuroblastoma cells

  2020cites this paper
• The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies.

  2020cites this paper
• Neurotoxicity including posterior reversible encephalopathy syndrome after initiation of calcineurin inhibitors in transplanted methylmalonic acidemia patients: Two case reports and review of the literature

  2020cites this paper
• Liver and/or kidney transplantation in amino and organic acid‐related inborn errors of metabolism: An overview on European data

  2020cites this paper
• Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision

  2019cites this paper
• Neurological manifestations of organic acidurias

  2019cites this paper
• Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias

  2018cites this paper
• Impairment of astrocytic glutaminolysis in glutaric aciduria type I

  2018cites this paper
• Mitochondrial acetoacetyl-CoA thiolase deficiency: basal ganglia impairment may occur independently of ketoacidosis

  2017cites this paper
• Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.

  2017cites this paper
• Generation of a Medaka Fish Model of Propionic Acidemia for Development of Novel Therapies

  2017cites this paper
• Experiences during newborn screening for glutaric aciduria type 1: Diagnosis, treatment, genotype, phenotype, and outcomes

  2017cites this paper
• 2‐Methylcitric acid impairs glutamate metabolism and induces permeability transition in brain mitochondria

  2016cites this paper
• Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria.

  2016cites this paper
• In vivo intracerebral administration of L-2-hydroxyglutaric acid provokes oxidative stress and histopathological alterations in striatum and cerebellum of adolescent rats.

  2015cites this paper
• A Mouse Model of L-2-Hydroxyglutaric Aciduria, a Disorder of Metabolite Repair

  2015cites this paper
• The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

  2015cites this paper
• Toxic synergism between quinolinic acid and organic acids accumulating in glutaric acidemia type I and in disorders of propionate metabolism in rat brain synaptosomes: Relevance for metabolic acidemias.

  2015cites this paper
• Rare Late-Onset Presentation of Glutaric Aciduria Type I in a 16-Year-Old Woman with a Novel GCDH Mutation.

  2015influential citation
• Predictors of survival in children with methymalonic acidemia with homocystinuria in Beijing, China: a prospective cohort study.

  2015cites this paper
• The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes.

  2015cites this paper
• Predictors of survival in children with methymalonic acidemia with homocystinuria in Beijing, China: A prospective cohort study

  2015cites this paper
• Renal manifestations of metabolic disorders in children

  2015cites this paper
• Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.

  2015cites this paper
• Single amino acid supplementation in aminoacidopathies: a systematic review

  2014cites this paper
• Neuroimaging in infants who present with inborn errors of metabolism

  2014cites this paper
• Single amino acid supplementation in aminoacidopathies

  2014cites this paper
• Disruption of redox homeostasis and histopathological alterations caused by in vivo intrastriatal administration of D-2-hydroxyglutaric acid to young rats.

  2014cites this paper
• Neurodevelopmental profiles of children with glutaric aciduria type I diagnosed by newborn screening: a follow-up case series.

  2014cites this paper
• Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models—a cohort study in 180 patients

  2014cites this paper
• Metabolite proofreading, a neglected aspect of intermediary metabolism

  2013cites this paper
• Perioperative management of a child with glutaric aciduria type I undergoing cardiac surgery.

  2013cites this paper
• Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation

  2013cites this paper
• Brain damage in methylmalonic aciduria: 2-methylcitrate induces cerebral ammonium accumulation and apoptosis in 3D organotypic brain cell cultures

  2013cites this paper
• Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist

  2013cites this paper
• Renal involvement in a patient with cobalamin A type (cblA) methylmalonic aciduria: a 42-year follow-up.

  2013cites this paper
• Suggested guidelines for the diagnosis and management of urea cycle disorders

  2012influential citation
• Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects

  2012cites this paper
• Caspase-3 mediates apoptosis of striatal cells in GA I rat model

  2012cites this paper
• Multimodal magnetic resonance investigation of childhood metabolic neurodegenerative disease

  2012cites this paper
• Gene therapy for methylmalonic aciduria.

  2012cites this paper
• Caspase-3 mediates apoptosis of striatal cells in GA I rat model

  2012cites this paper
• Neurologic considerations in propionic acidemia.

  2012cites this paper
• Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.

  2012cites this paper
• Patients with organic acidaemias have an altered thiol status

  2012cites this paper
• Glutaric aciduria type I: A translational approach to an enigmatic disease

  2011cites this paper
• Experimental Evidence that Methylmalonic Acid Provokes Oxidative Damage and Compromises Antioxidant Defenses in Nerve Terminal and Striatum of Young Rats

  2011cites this paper
• Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.

  2011cites this paper
• Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia

  2011cites this paper
• Lactic acidosis: recognition, kinetics, and associated prognosis.

  2010cites this paper
• Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus.

  2010cites this paper
• Spontaneous Rapid Resolution of Acute Basal Ganglia Changes in an Untreated Infant with Propionic Acidemia: A Clue to Pathogenesis?

  2010cites this paper
• Induction of S100B secretion in C6 astroglial cells by the major metabolites accumulating in glutaric acidemia type I

  2010influential citation
• For Peer Review Spontaneous rapid resolution of acute Basal Ganglia changes in an untreated infant with Propionic Acidemia: A clue to pathogenesis ?

  2010cites this paper
• Promotion of Lipid and Protein Oxidative Damage in Rat Brain by Ethylmalonic Acid

  2010cites this paper
• Evidence for catabolic pathway of propionate metabolism in CNS: expression pattern of methylmalonyl-CoA mutase and propionyl-CoA carboxylase alpha-subunit in developing and adult rat brain.

  2009cites this paper
• Cognitive, behavioural and adaptive profiles of children with glutaric aciduria type I detected through newborn screening

  2009cites this paper
• Long-term outcome in methylmalonic aciduria: a series of 30 French patients.

  2009cites this paper
• Stroke-Like Episodes in Propionic Acidemia Caused by Central Focal Metabolic Decompensation

  2009cites this paper
• Glutaric aciduria type 1 presenting with epilepsy

  2009cites this paper
• Looking beyond the basal ganglia: The spectrum of MRI changes in methylmalonic acidaemia

  2008cites this paper
• Hereditary and acquired diseases of acyl-coenzyme A metabolism.

  2008cites this paper
• Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome.

  2008cites this paper
• Different outcome in isovaleric acidemia might be related to unsatisfactory diet compliance

  2008cites this paper
• Neurodegeneration and chronic renal failure in methylmalonic aciduria—A pathophysiological approach

  2008cites this paper
• New indications and controversies in arginine therapy.

  2008cites this paper
• Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism

  2008cites this paper
• Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency

  2007cites this paper
• Recent advances in amino acid and organic acid metabolism

  2007cites this paper
• Leukodystrophies: Clinical and Genetic Aspects

  2006cites this paper
• Commentary on: The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. Kölker S, Sauer SW, Surtees RAH, Leonard JV

  2006cites this paper